Hessvik NP, Llorente A. Adenomatous Polyposis Coli (APC), a poor WNT signaling pathway regulator, adding to the activation of WNT signaling pathway and cardiac fibroblast…
Advances in the clinical development of PI3K inhibitors
PI3K inhibitor
Hessvik NP, Llorente A. Adenomatous Polyposis Coli (APC), a poor WNT signaling pathway regulator, adding to the activation of WNT signaling pathway and cardiac fibroblast…